Basic information Safety Supplier Related

(+/-)-3-AMINO-1,2,3,4-TETRAHYDROQUINOLINE

Basic information Safety Supplier Related

(+/-)-3-AMINO-1,2,3,4-TETRAHYDROQUINOLINE Basic information

Product Name:
(+/-)-3-AMINO-1,2,3,4-TETRAHYDROQUINOLINE
Synonyms:
  • (+/-)-3-AMINO-1,2,3,4-TETRAHYDROQUINOLINE
  • 3-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DIHYDROCHLORIDE
  • (-3-Amino-1,2,3,4-tetrahydroquinoline2HCl
  • ()-3-AMINO-1,2,3,4-TETRAHYDROQUINOLINE 2HC
  • 3-QuinolinaMine, 1,2,3,4-tetrahydro-
  • 1,2,3,4-Tetrahydroquinolin-3-aMine
  • 1,2,3,4-Tetrahydro-3-quinolinamine
  • (+/-)-3-Amino-1,2,3,4-tetrahydroquinoline
CAS:
40615-02-9
MF:
C9H12N2
MW:
148.21
Product Categories:
  • pharmacetical
Mol File:
40615-02-9.mol
More
Less

(+/-)-3-AMINO-1,2,3,4-TETRAHYDROQUINOLINE Chemical Properties

Boiling point:
292.1±29.0 °C(Predicted)
Density 
1.059±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
pka
8.10±0.20(Predicted)
Appearance
Brown to black Solid
More
Less

(+/-)-3-AMINO-1,2,3,4-TETRAHYDROQUINOLINE Usage And Synthesis

Uses

1,2,3,4-Tetrahydroquinolin-3-amine is used in the preparation of state-dependant NaV1.7 inhibitors for the treatment of neuropathic pain.

Synthesis

580-17-6

40615-02-9

GENERAL METHOD: In a 1.5 mL reaction vial, tris(pentafluorophenyl)borane [B(C6F5)3] (0.025 mmol, 5.0 mol%) was dissolved in chloroform (0.60 mL), followed by the addition of diethylsilane (1.75 mmol, 3.5 equiv). After a short shaking, quinoline derivative (1a-p, 0.50 mmol, 1.0 eq.) was added to the above catalyst solution under argon protection. The reaction mixture was stirred at 25-65 °C for 6-24 h (for 1a-h) or at 25-100 °C for 2-24 h (for 1i-p) and subsequently cooled to room temperature. The reaction mixture was concentrated under reduced pressure to give the crude product. The crude product was treated with an ether solution (7 mL) of 0.25 N HCl and stirred at room temperature for 1 h to give a solid residue, which was subsequently washed with ether. The solid residue was dissolved or suspended in methanol (1.0 mL) and neutralized with sodium carbonate monohydrate (Na2CO3-H2O, 0.5 g) at 0 °C. After stirring for 2 h, methanol was removed under reduced pressure and the neutralized reaction residue was dissolved in dichloromethane (CH2Cl2) and washed sequentially with brine (5 mL) and water (5 mL). The crude product was isolated from the organic phase of the dichloromethane solution and finally purified by silica gel column chromatography using ethyl acetate/hexane (1:9 for 2a-h; 3:7 for 2i-p) as eluent to give the target product 2a-p.

References

[1] Synlett, 2017, vol. 28, # 18, p. 2396 - 2400
[2] Journal of Medicinal Chemistry, 1982, vol. 25, # 1, p. 68 - 70
[3] Patent: US5719141, 1998, A

(+/-)-3-AMINO-1,2,3,4-TETRAHYDROQUINOLINESupplier

Carbott PharmTech Inc.
Tel
0535-6385396
Email
info@carbottpharm.com
Hangzhou Sage Chemical Co., Ltd.
Tel
+86057186818502 13588463833
Email
info@sagechem.com
Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com
Aikon International Limited
Tel
025-58859352 18068836627
Email
sales01@aikonchem.com
Shanghai WangFa Chemical Technology Co., Ltd.
Tel
13918479294
Email
xiebenfa@163.com